Vizsgálati helyszín
Retina Research Institute of Texas
Abilene, Texas 79606, Egyesült ÁllamokMég nincs intézményhez kötve
- 17futó vizsgálat
- 12lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 29 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis14 vizsgálat
- 2. fázis7 vizsgálat
- 1/2. fázis3 vizsgálat
- 1. fázis2 vizsgálat
- 2/3. fázis1 vizsgálat
- Állapot
- Lezárult12 vizsgálat
- Fut, nem toboroz11 vizsgálat
- Toboroz5 vizsgálat
- Még nem toboroz1 vizsgálat
- Fő szponzor
- Kodiak Sciences Inc4 vizsgálat
- Hoffmann-La Roche3 vizsgálat
- Genentech, Inc.2 vizsgálat
- Kyowa Kirin Co., Ltd.2 vizsgálat
- Regeneron Pharmaceuticals2 vizsgálat
- és még 16
Futó vizsgálatok
Toboroz
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
NCT07029945· 1/2. fázis· Biojiva LLC· Forrás
Contact: Clinical Study Coordinator
Toboroz
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
NCT07425522· 1. fázis· Genentech, Inc.· Forrás
Toboroz
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
NCT06990399· 3. fázis· Kodiak Sciences Inc· Forrás
Contact: Kodiak Sciences Inc
Toboroz
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
NCT06996080· 3. fázis· Kodiak Sciences Inc· Forrás
Contact: Kodiak Sciences Inc
Még nem toboroz
A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration
NCT06470373· 3. fázis· Rophibio, Inc.· Forrás
Contact: Deisy Villareal
Fut, nem toboroz
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
NCT06864988· 3. fázis· 4D Molecular Therapeutics· Forrás
Fut, nem toboroz
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
NCT06779773· Astellas Pharma Global Development, Inc.· Forrás
Fut, nem toboroz
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration
NCT06495918· 3. fázis· Ocular Therapeutix, Inc.· Forrás
Toboroz
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
NCT06541704· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK
NCT06556368· 3. fázis· Kodiak Sciences Inc· Forrás
Fut, nem toboroz
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
NCT06510816· 3. fázis· Annexon, Inc.· Forrás
Fut, nem toboroz
A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)
NCT06491914· 3. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
NCT06373731· 3. fázis· Stealth BioTherapeutics Inc.· Forrás
Fut, nem toboroz
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema
NCT06116916· 2. fázis· Kyowa Kirin Co., Ltd.· Forrás
Fut, nem toboroz
Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)
NCT05769153· 1/2. fázis· Alcon Research· Forrás
Fut, nem toboroz
Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration
NCT05904691· 1. fázis· Ocugenix Corporation· Forrás
Fut, nem toboroz
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
NCT04108156· 3. fázis· Hoffmann-La Roche· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)
NCT06270836· 3. fázis· Kodiak Sciences Inc· Forrás
Lezárult
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
NCT06116890· 2. fázis· Kyowa Kirin Co., Ltd.· Forrás
Lezárult
Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration
NCT05891548· 2. fázis· Clearside Biomedical, Inc.· Forrás
Lezárult
Vamikibart in Participants With Uveitic Macular Edema
NCT05642325· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT05811351· 2. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study
NCT05797896· Complement Therapeutics· Forrás
Lezárult
QA102 Phase II Study in Subjects With Dry AMD
NCT05536752· 2. fázis· Smilebiotek Zhuhai Limited· Forrás
Lezárult
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
NCT06850922· 1/2. fázis· Genentech, Inc.· Forrás
Lezárult
A Single Ascending Dose Cohort Study of AG-73305 in DME Patients
NCT05301751· 2. fázis· Allgenesis Biotherapeutics Inc.· Forrás
Lezárult
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)
NCT05066997· 2/3. fázis· Oculis· Forrás
Lezárult
A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm
NCT04503551· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
NCT04527107· 2. fázis· Oxurion· Forrás
Hibát jelzek